Meridian Wealth Advisors, LLC Amgen Inc Transaction History

Meridian Wealth Advisors, LLC

$482 Million
Q1 2024

A detailed history of Meridian Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Meridian Wealth Advisors, LLC holds 8,008 shares of AMGN stock, worth $2.5 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

8,008

Previous 8,198 2.32%

Holding current value

$2.5 Million

Previous $2.36 Million 3.6%

% of portfolio

0.47%

Previous 0.54%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $51,085 - $61,666	-190 Reduced 2.32%	8,008 $2.28 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $2,186 - $2,714	-10 Reduced 0.12%	8,198 $2.2 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $98,564 - $116,550	-460 Reduced 5.31%	8,208 $1.82 Million
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $2,519 - $3,201	-11 Reduced 0.13%	8,668 $0
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $8,753 - $9,872	-39 Reduced 0.45%	8,679 $1.96 Million

Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $57,677 - $64,185	-250 Reduced 2.79%	8,718 $2.12 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $74,551 - $82,473	340 Added 3.94%	8,968 $2.17 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $9,944 - $11,380	-50 Reduced 0.58%	8,628 $1.94 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $82,785 - $96,993	-390 Reduced 4.3%	8,678 $1.85 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $395,217 - $438,464	-1,692 Reduced 15.72%	9,068 $2.21 Million
Q4 2020 May 07, 2021	BUY	$216.38 - $257.67 $2.25 Million - $2.67 Million	10,380 Added 2731.58%	10,760 $2.47 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $2.26 Million - $2.69 Million	-10,429 Reduced 96.48%	380 $92,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $32,851 - $36,533	140 Added 1.31%	10,809 $2.75 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $431,225 - $529,173	2,180 Added 25.68%	10,669 $2.52 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $19,681 - $26,103	-108 Reduced 1.26%	8,489 $1.72 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $10,098 - $12,099	58 Added 0.68%	8,597 $1.66 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $10,002 - $11,724	-60 Reduced 0.7%	8,539 $1.59 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.53 Million - $1.79 Million	8,599 New	8,599 $1.67 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Advisors, LLC with notifications on news.

Account

Meridian Wealth Advisors, LLC Amgen Inc Transaction History